There were many precursors to Andreas Grüntzig whose work made his achievement possible. The Exposition features a gallery of six of these pioneers. One such visionary was Charles Dotter (1920–1985), who in 1963, with the first use of a diagnostic catheter for a therapeutic purpose, invented...

Andreas Grüntzig’s vision and perspicacity drove an entire new field of cardiology. This page is dedicated to his personal life and accomplishments with a dedicated tribute from Spencer B. King III

An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...

An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...

Join us for a LIVE case followed by a recorded case highlighting advanced treatments for severe secondary mitral regurgitation:

• A 75-year-old man with permanent AF, a history of CABG, and symptomatic severe secondary MR (atrial and ischemic causes) with low LV function (45%) underwent mitral repair with...

A 53-year-old male with a history of advanced malignancy (lung adenoma) and mid LAD PCI last year, along with multiple risk factors (hypertension, dyslipidemia, diabetes, and smoking), presented with angina and a positive stress test and CT. The angiography and CT showed significant left main stenosis...

A 77-year-old male with a history of SAVR in 2011 (Magna Ease 23) and moderate chronic kidney disease, with preservedLV function, presented with symptomatic severe aortic regurgitation and stenosis, associated with severe MR.

A Sapien 3 Ultra Resilia 23 valve was implanted under local anesthesia, with hemodynamic...

This new "disruptive" technology is among the most important medical breakthroughs to date. TAVI emerged in 2002 to profoundly alter the landscape of cardiovascular medicine.

In 2002, Alain Cribier revolutionised the field by introducing transcatheter aortic valve implantation (TAVI) as a complementary technique to surgery. Find out more about his early life and studies.

Philippe Gaspard, an interventional cardiologist with over 35 years’ experience, was a firsthand witness of angioplasty’s early years. In his book “The History of Coronary Angioplasty” the author guides us through the field’s evolution while offering personal insights into the “paradigm shift” that followed the work...

Alex Sticchi provides his take on the OCCUPI trial presented by Kim Byeong-Keuk at the ESC Congress 2024 in London.